ROIV

11.66

1.13% 0.13

Dopo l'orario di chiusura: 11.70 0.04 +0.34%

Roivant Sciences Ltd (ROIV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ROIV Giù? Forum Previsione

Precedente Chiudi:

$11.53

Aprire:

$11.5

Volume 24 ore:

2.51M

Relative Volume:

0.43

Capitalizzazione di mercato:

$8.62B

Reddito:

$158.30M

Utile/perdita netta:

$4.74B

Rapporto P/E:

-8.7015

EPS:

-1.34

Flusso di cassa netto:

$-710.11M

1 W Prestazione:

+0.69%

1M Prestazione:

+2.46%

6M Prestazione:

+2.37%

1 anno Prestazione:

+25.65%

Intervallo 1D:

$11.40

$11.67

Intervallo di 1 settimana:

$11.40

$11.83

Portata 52W:

$8.465

$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Nome

Roivant Sciences Ltd

Settore

Healthcare (1182)

Industria

Biotechnology (671)

Telefono

441-295-5950

Indirizzo

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11

Dipendente

908

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

ROIV's Discussions on Twitter

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-15	Iniziato	Wolfe Research	Outperform
2024-01-05	Iniziato	Piper Sandler	Overweight
2023-12-12	Iniziato	Deutsche Bank	Buy
2023-10-17	Iniziato	Guggenheim	Buy
2023-06-08	Iniziato	BofA Securities	Neutral
2022-10-27	Iniziato	JP Morgan	Overweight
2022-05-23	Iniziato	SVB Leerink	Outperform
2022-04-29	Iniziato	Cantor Fitzgerald	Overweight
2021-12-15	Iniziato	Goldman	Buy
2021-11-08	Iniziato	H.C. Wainwright	Buy
2021-10-28	Iniziato	Citigroup	Buy
2021-10-26	Iniziato	Cowen	Outperform
2021-10-26	Iniziato	Jefferies	Buy
2021-10-26	Iniziato	Truist	Buy

Mostra tutto

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

05:08 AM

Vanguard Group Inc's Strategic Acquisition in Roivant Sciences L - GuruFocus.com

05:08 AM

01:05 AM

Roivant Sciences (ROIV) Scheduled to Post Earnings on Tuesday - MarketBeat

01:05 AM

06:53 AM

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Impax Asset Management Group plc - MarketBeat

06:53 AM

Nov 04, 2024

Allspring Global Investments Holdings LLC Sells 115,694 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 04, 2024

Oct 29, 2024

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 - Yahoo Finance

Oct 29, 2024

Organon Completes Acquisition of Dermavant - njbmagazine.com

Oct 29, 2024

China Universal Asset Management Co. Ltd. Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Oct 29, 2024

Organon completes Dermavant Sciences acquisition By Investing.com - Investing.com Canada

Oct 29, 2024

Oct 28, 2024

Organon completes Dermavant Sciences acquisition - Investing.com

Oct 28, 2024

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - StockTitan

Oct 28, 2024

Oct 23, 2024

At Roivant Sciences, Eric Venker Chooses To Exercise Options, Resulting In $782K - Benzinga

Oct 23, 2024

Options Exercise: Eric Venker At Roivant Sciences Realizes $782K - Benzinga

Oct 23, 2024

Oct 22, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 Shares - MarketBeat

Oct 22, 2024

Roivant Sciences president sells $1.17 million in shares By Investing.com - Investing.com Australia

Oct 22, 2024

Roivant Sciences president sells $1.17 million in shares - Investing.com

Oct 22, 2024

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) - Seeking Alpha

Oct 22, 2024

Leerink maintains outperform on Roivant with steady target By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 20, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 20, 2024

Oct 17, 2024

Roivant Sciences (ROIV): High-Growth UK Stock with Innovative Drug Development Model - Insider Monkey

Oct 17, 2024

Oct 15, 2024

Exchange Traded Concepts LLC Makes New $2.27 Million Investment in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Oct 15, 2024

Oct 14, 2024